TofimilastAlternative Names: CP 325366
Latest Information Update: 12 Aug 2008
At a glance
- Originator Pfizer
- Class 3-ring heterocyclic compounds; Antiasthmatics; Bronchodilators; Small molecules
- Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Asthma; Chronic obstructive pulmonary disease
Most Recent Events
- 07 Jun 2002 unspecified for Asthma in USA (unspecified route)